-
Mashup Score: 0The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity - 3 year(s) ago
This Medical News article discusses why experts recommend against patients getting antibody testing to assess their protection from SARS-CoV-2 after vaccination or infection.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection | Blood | American Society of Hematology - 3 year(s) ago
The authors present a retrospective analysis of bleeding and thrombosis in 400 patients hospitalized with COVID-19. They report venous thromboembolism and bleed
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection [Jul 23, 2020] @HannyAlSamkari et al. @BloodJournal https://t.co/7DU3ecoIpX #VTE #2019nCoV #COVID19 #CCC19 @COVID19nCCC https://t.co/yLgcMZ7TPF
-
-
Mashup Score: 2The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19 - 3 year(s) ago
Background Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a …
Source: Wiley Online LibraryCategories: Hem/Oncs, Latest HeadlinesTweet-
The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19 [Jul 14, 2021] @AngLi_MD et al. @RosovskyRachel @COVID19nCCC @JTHjournal https://t.co/MjGaZvfrrW #VTE #2019nCoV #COVID19 #CCC19 https://t.co/fIg04CQJ81
-
-
Mashup Score: 0JCI - The convalescent sera option for containing COVID-19 - 3 year(s) ago
To deploy convalescent serum administration for COVID-19 the following six conditions must be met: (i) availability of a population of donors who have recovered from the disease and can donate convalescent serum; (ii) blood banking facilities to process the serum donations; (iii) availability of assays, including serological assays, to detect SARS-CoV-2 in serum and virological assays to measure…
Source: www.jci.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
The convalescent sera option for containing COVID-19 [Mar 13, 2020] @ACasadevall1 & Pirofski @jclinicalinvest https://t.co/atbKqAqVbL #2019nCoV #coronavirus #COVID19 https://t.co/sSoRcsMWtY
-
-
Mashup Score: 0Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination - Nature Medicine - 3 year(s) ago
In a study of healthcare professionals previously vaccinated with ChAdOx-1 nCoV-19, booster vaccination with BNT162b2 elicited more neutralizing antibodies with greater breadth, as well as higher frequencies of virus-specific T cells, than ChAdOx-1 nCoV-19.
Source: Nature MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination [Jul 14, 2021] @JoenaMartins et al. @NatureMedicine https://t.co/smRXn5zZRK #2019nCoV #COVID19Vaccine #COVID19 https://t.co/LjZQmJYQTq
-
-
Mashup Score: 0The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19 - 3 year(s) ago
Background Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a …
Source: Wiley Online LibraryCategories: Hem/Oncs, Latest HeadlinesTweet-
The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19 [Jul 14, 2021] @AngLi_MD et al. @COVID19nCCC @JTHjournal https://t.co/MjGaZvfrrW #VTE #2019nCoV #COVID19 #CCC19 https://t.co/gZ8dBJHnWp
-
-
Mashup Score: 2Home - T-Detect - 3 year(s) ago
T cells are key players in the adaptive immune system. When the body is invaded by a foreign substance like a virus or bacteria, the immune system begins to rally one of its earliest lines of defense, helper T cells, to join the fight.
Categories: Hem/Oncs, Latest HeadlinesTweet-
(I haven't used this, but...) -> T-Detect COVID is a T cell test that may confirm a recent or past COVID-19 infection. @AdaptiveBiotech https://t.co/m1PSiDYm25 #2019nCoV #COVID19 #Testing cc #IDonc #COVID19nCancer #CCC19
-
-
Mashup Score: 11
Decoding the immune response to the virus from thousands of patient samples may contribute to the development of novel diagnostics, vaccines and therapeutics Data will be updated regularly and made freely available to researchers and public health officials around the world SEATTLE and REDMOND, Wash. — June 11, 2020 — Adaptive Biotechnologies Corp. (Nasdaq: ADPT) […]
Source: StoriesCategories: Hem/Oncs, Latest HeadlinesTweet-
. @AdaptiveBiotech and Microsoft launch groundbreaking ImmuneCODE database to share populationwide immune response to the COVID-19 virus [Jun 11, 2020] @Microsoft News Center https://t.co/kK4ztCx4XK #CCC19 #2019nCoV #COVID19 @COVID19nCCC
-
-
Mashup Score: 0
-
NEW THREAD on questions I’m asking (myself) for potential 3rd mRNA immunization in eligible adults/adolescents as a means to prevent pediatric infections: Given preliminary evidence of 1,000X higher viral loads and shedding in those infected with delta https://t.co/2d09F3fFoF
Read the original tweet here
Source: TwitterCategories: Hem/Oncs, Latest HeadlinesTweet-
MT @PeterHotez [7/21/21] THREAD on questions I’m asking (myself) for potential 3rd mRNA immunization in eligible adults/adolescents as a means to prevent pediatric infections: https://t.co/7UBfyJJwUP #COVID19 #COVID19Vaccine #2019nCoV #Delta #VariantDelta
-
-
Mashup Score: 1The CoVID‐TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID‐19 - 3 year(s) ago
Background Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a…
Source: Wiley Online LibraryCategories: Hem/Oncs, Latest HeadlinesTweet-
The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19 [Jul 14, 2021] @AngLi_MD et al. @RosovskyRachel @COVID19nCCC @JTHjournal https://t.co/MjGaZvfrrW #VTE #2019nCoV #COVID19 #CCC19
-
The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity [Oct 21, 2021] Jennifer Abbasi @JAMANetwork https://t.co/VtEKQSf986 #2019nCoV #COVID19 #COVID19Vaccine #Testing https://t.co/7elz6olRSP